Internal Medicine, Interventional Cardiology · Los Alamitos, CA
NPI
1629074877
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3801 Katella Ave, Suite 401
Los Alamitos, CA, 90720
Phone (562) 598-3200
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
59,159 services
Medicare patients, 2024
986
Average age 78
Drug cost, 2024
$1.9M
8,941 prescriptions
Company payments, 2025
$801
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruce E Vannatta was code J1306 (injection, inclisiran, 1 mg), 26,056 times for 53 patients. In total Bruce E Vannatta billed 59,159 services in 130 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 26,056 | 53 | $9.53 | $248K |
| 36415 Venipuncture Blood Collection | Office | 1,081 | 676 | $6.86 | $7,416 |
| 80061 Clinical Chemistry | Office | 1,046 | 670 | $13.12 | $14K |
| 83880 Clinical Chemistry | Office | 1,042 | 666 | $38.47 | $40K |
| 83036 Blood Count | Office | 1,038 | 666 | $9.52 | $9,882 |
| 86141 Clinical Chemistry | Office | 1,037 | 664 | $12.69 | $13K |
| 84439 Clinical Chemistry | Office | 1,035 | 665 | $8.84 | $9,149 |
| 84550 Clinical Chemistry | Office | 1,035 | 664 | $4.43 | $4,585 |
| 82550 Clinical Chemistry | Office | 1,034 | 664 | $6.38 | $6,597 |
| 83735 Clinical Chemistry | Office | 1,033 | 664 | $6.57 | $6,787 |
| 80053 Clinical Chemistry | Office | 1,032 | 661 | $10.35 | $11K |
| 84443 Clinical Chemistry | Office | 1,029 | 660 | $16.46 | $17K |
| 85025 Blood Count | Office | 1,027 | 659 | $7.61 | $7,815 |
| 82248 Clinical Chemistry | Office | 927 | 567 | $4.92 | $4,561 |
| 99214 Office E&M - Established | Office | 665 | 513 | $98.18 | $65K |
By year: 2022 $757K for 42,262 services; 2023 $833K for 48,013 services; 2024 $1.2M for 59,159 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,081 | 676 | $6.86 | $7,416 |
| 80061 Clinical Chemistry | 1,046 | 670 | $13.12 | $14K |
| 83880 Clinical Chemistry | 1,042 | 666 | $38.47 | $40K |
| 83036 Blood Count | 1,038 | 666 | $9.52 | $9,882 |
| 86141 Clinical Chemistry | 1,037 | 664 | $12.69 | $13K |
| 84439 Clinical Chemistry | 1,035 | 665 | $8.84 | $9,149 |
| 84550 Clinical Chemistry | 1,035 | 664 | $4.43 | $4,585 |
| 82550 Clinical Chemistry | 1,034 | 664 | $6.38 | $6,597 |
| 83735 Clinical Chemistry | 1,033 | 664 | $6.57 | $6,787 |
| 80053 Clinical Chemistry | 1,032 | 661 | $10.35 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Bruce E Vannatta prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,246 prescriptions and refills. In total Bruce E Vannatta wrote 8,941 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,246 | 3,617 | 373 | $22K |
| Ezetimibe Generic | 561 | 1,657 | 182 | $18K |
| Losartan Potassium Generic | 454 | 1,271 | 147 | $5,580 |
| Amlodipine Besylate Generic | 447 | 1,289 | 139 | $3,693 |
| Repatha Sureclick Evolocumab | 354 | 490 | 51 | $272K |
| Carvedilol Generic | 316 | 924 | 104 | $3,493 |
| Praluent Pen Alirocumab | 313 | 377 | 44 | $186K |
| Xarelto Rivaroxaban | 236 | 538 | 59 | $288K |
| Levothyroxine Sodium Generic | 219 | 652 | 67 | $3,006 |
| Eplerenone Generic | 218 | 606 | 67 | $28K |
| Eliquis Apixaban | 218 | 538 | 59 | $300K |
| Telmisartan Generic | 201 | 560 | 69 | $6,592 |
| Jardiance Empagliflozin | 173 | 378 | 41 | $212K |
| Allopurinol Generic | 156 | 444 | 46 | $1,416 |
| Atorvastatin Calcium Generic | 155 | 448 | 49 | $1,270 |
Brand drugs: - claims; generic drugs: 7,143 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruce E Vannatta $801 ($801 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novo Nordisk Inc with $254.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 3 | $254 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $170 |
| Amgen Inc. AMGN | 3 | $83.6 |
| Abiomed JNJ | 3 | $78.35 |
| Pfizer Inc. PFE | 2 | $47.25 |
| Recor Medical Inc | 2 | $39.25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26.48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21.62 |
| AtriCure, Inc. ATRC | 1 | $21.12 |
| Merck Sharp & Dohme LLC MRK | 1 | $19.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.